Autopsy report · NCT03232021
Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations
Cause of deathSlow enrollment
“All patients during the study period were subjected to peripheral blocks or were excluded from the study due to exclusion criteria”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2, Phase 3
- Sponsor
- Saint Savvas Anticancer Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Pregabalin on Catheter Related Bladder Discomfort
- Interventions
- Placebo oral capsule; Pregabalin Oral Capsule [Lyrica] 75mg; Pregabalin Oral Capsule [Lyrica] 150 mg
- Participants
- 0
- Sites
- 2
- Countries
- Greece
Trials that died the same way
- Administration of Fibrinogen Concentrate for Refractory Bleeding
“Only one patient was included in this study due to overly restrictive inclusion and exclusion criteria.” - Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
“The study was stopped due to difficulties in including patients” - Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
“No patient corresponding to inclusion criteria couldn't be enrolled in the study” - Bioavailability of Voriconazole
“no eligible patients; study stopped without inclusion” - A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole
“No suitable patients and many patients refused the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.